Skip to main content
Top
Published in: BMC Nephrology 1/2013

Open Access 01-12-2013 | Research article

The use of absolute values improves performance of estimation formulae: a retrospective cross sectional study

Authors: Belén Redal-Baigorri, Knud Rasmussen, James Goya Heaf

Published in: BMC Nephrology | Issue 1/2013

Login to get access

Abstract

Background

Estimation of Glomerular Filtration Rate (GFR) by equations such as Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) or Modification of Diet in Renal Disease (MDRD) is usually expressed as a Body Surface Area (BSA) indexed value (ml/min per 1.73 m2). This can have severe clinical consequences in patients with extreme body sizes, resulting in an underestimation in the case of obesity or an overestimation of GFR in the case of underweight patients. The aim of this study was to compare the performance of both estimation formula expressed in ml/min, instead of ml/min per 1.73 m2, with a reference method.

Methods

Retrospective single centre cross sectional study of 185 patients. GFR was measured with 51Cr-EDTA and estimated with CKD-EPI and MDRD. Bias, precision and accuracy of absolute estimated GFR was calculated.

Results

Bias of CKD-EPI and MDRD formulae expressed as an absolute value was 0.49 and 0.27 ml/min respectively, which is lower than previously reported. Precision was 12.95 and 16.33 and accuracy expressed as P30 was over 92.43% for CKD-EPI. There were no significant differences in GFR between the reference method and the estimation formulae.

Conclusions

The performance of CKD-EPI and MDRD formulae can be significantly improved in the individual patient if the absolute values are used by removing the BSA normalization factor. Absolute estimated GFR by CKD-EPI is comparable to measured GFR, improving the performance of this formula in the assessment of individual kidney function, thus providing clinicians with an alternative to reference methods.
Appendix
Available only for authorised users
Literature
1.
go back to reference Stevens LA, Levey AS: Measured GFR as a confirmatory test for estimated GFR. J Am Soc Nephrol. 2009, 20: 2305-2313. 10.1681/ASN.2009020171.CrossRefPubMed Stevens LA, Levey AS: Measured GFR as a confirmatory test for estimated GFR. J Am Soc Nephrol. 2009, 20: 2305-2313. 10.1681/ASN.2009020171.CrossRefPubMed
2.
go back to reference Heaf JG: The origin of the 1 × 73-m2 body surface area normalization: problems and implications. Clin Physiol Funct Imaging. 2007, 27: 135-137. 10.1111/j.1475-097X.2006.00718.x.CrossRefPubMed Heaf JG: The origin of the 1 × 73-m2 body surface area normalization: problems and implications. Clin Physiol Funct Imaging. 2007, 27: 135-137. 10.1111/j.1475-097X.2006.00718.x.CrossRefPubMed
3.
go back to reference Si H, Lei Z, Li S, Liu J, Geng J, Chen S: Lean body mass is better than body surface area in correcting GFR. Clin Nucl Med. 2013, 38 (5): e210-e215. 10.1097/RLU.0b013e318263905b.CrossRefPubMed Si H, Lei Z, Li S, Liu J, Geng J, Chen S: Lean body mass is better than body surface area in correcting GFR. Clin Nucl Med. 2013, 38 (5): e210-e215. 10.1097/RLU.0b013e318263905b.CrossRefPubMed
4.
go back to reference Peters AM, Perry L, Hooker CA, Howard B, Neilly MD, Seshadri N, et al: Extracellular fluid volume and glomerular filtration rate in 1878 healthy potential renal transplant donors: effects of age, gender, obesity and scaling. Nephrol Dial Transplant. 2012, 27: 1429-1437. 10.1093/ndt/gfr479.CrossRefPubMed Peters AM, Perry L, Hooker CA, Howard B, Neilly MD, Seshadri N, et al: Extracellular fluid volume and glomerular filtration rate in 1878 healthy potential renal transplant donors: effects of age, gender, obesity and scaling. Nephrol Dial Transplant. 2012, 27: 1429-1437. 10.1093/ndt/gfr479.CrossRefPubMed
5.
go back to reference Kaag D: Carboplatin dose calculation in lung cancer patients with low serum creatinine concentrations using CKD-EPI and Cockcroft-Gault with different weight descriptors. Lung Cancer. 2013, 79: 54-58. 10.1016/j.lungcan.2012.10.009.CrossRefPubMed Kaag D: Carboplatin dose calculation in lung cancer patients with low serum creatinine concentrations using CKD-EPI and Cockcroft-Gault with different weight descriptors. Lung Cancer. 2013, 79: 54-58. 10.1016/j.lungcan.2012.10.009.CrossRefPubMed
6.
go back to reference Delanaye P, Radermecker RP, Rorive M, Depas G, Krzesinski JM: Indexing glomerular filtration rate for body surface area in obese patients is misleading: concept and example. Nephrol Dial Transplant. 2005, 20: 2024-2028. 10.1093/ndt/gfh983.CrossRefPubMed Delanaye P, Radermecker RP, Rorive M, Depas G, Krzesinski JM: Indexing glomerular filtration rate for body surface area in obese patients is misleading: concept and example. Nephrol Dial Transplant. 2005, 20: 2024-2028. 10.1093/ndt/gfh983.CrossRefPubMed
7.
go back to reference Ribstein J, du CG, Mimran A: Combined renal effects of overweight and hypertension. Hypertension. 1995, 26: 610-615. 10.1161/01.HYP.26.4.610.CrossRefPubMed Ribstein J, du CG, Mimran A: Combined renal effects of overweight and hypertension. Hypertension. 1995, 26: 610-615. 10.1161/01.HYP.26.4.610.CrossRefPubMed
8.
go back to reference Chagnac A, Herman M, Zingerman B, Erman A, Rozen-Zvi B, Hirsh J, et al: Obesity-induced glomerular hyperfiltration: its involvement in the pathogenesis of tubular sodium reabsorption. Nephrol Dial Transplant. 2008, 23: 3946-3952. 10.1093/ndt/gfn379.CrossRefPubMed Chagnac A, Herman M, Zingerman B, Erman A, Rozen-Zvi B, Hirsh J, et al: Obesity-induced glomerular hyperfiltration: its involvement in the pathogenesis of tubular sodium reabsorption. Nephrol Dial Transplant. 2008, 23: 3946-3952. 10.1093/ndt/gfn379.CrossRefPubMed
9.
go back to reference Wuerzner G, Pruijm M, Maillard M, Bovet P, Renaud C, Burnier M, et al: Marked association between obesity and glomerular hyperfiltration: a cross-sectional study in an African population. Am J Kidney Dis. 2010, 56: 303-312. 10.1053/j.ajkd.2010.03.017.CrossRefPubMed Wuerzner G, Pruijm M, Maillard M, Bovet P, Renaud C, Burnier M, et al: Marked association between obesity and glomerular hyperfiltration: a cross-sectional study in an African population. Am J Kidney Dis. 2010, 56: 303-312. 10.1053/j.ajkd.2010.03.017.CrossRefPubMed
10.
go back to reference Levey AS, Kramer H: Obesity, glomerular hyperfiltration, and the surface area correction. Am J Kidney Dis. 2010, 56: 255-258. 10.1053/j.ajkd.2010.06.005.CrossRefPubMed Levey AS, Kramer H: Obesity, glomerular hyperfiltration, and the surface area correction. Am J Kidney Dis. 2010, 56: 255-258. 10.1053/j.ajkd.2010.06.005.CrossRefPubMed
11.
go back to reference Delanaye P, Mariat C, Cavalier E, Krzesinski JM: Errors induced by indexing glomerular filtration rate for body surface area: reductio ad absurdum. Nephrol Dial Transplant. 2009, 24: 3593-3596. 10.1093/ndt/gfp431.CrossRefPubMed Delanaye P, Mariat C, Cavalier E, Krzesinski JM: Errors induced by indexing glomerular filtration rate for body surface area: reductio ad absurdum. Nephrol Dial Transplant. 2009, 24: 3593-3596. 10.1093/ndt/gfp431.CrossRefPubMed
12.
go back to reference Hudson JQ, Nyman HA: Use of estimated glomerular filtration rate for drug dosing in the chronic kidney disease patient. Curr Opin Nephrol Hypertens. 2011, 20: 482-491. 10.1097/MNH.0b013e328348c11f.CrossRefPubMed Hudson JQ, Nyman HA: Use of estimated glomerular filtration rate for drug dosing in the chronic kidney disease patient. Curr Opin Nephrol Hypertens. 2011, 20: 482-491. 10.1097/MNH.0b013e328348c11f.CrossRefPubMed
13.
go back to reference Geddes CC, Woo YM, Brady S: Glomerular filtration rate–what is the rationale and justification of normalizing GFR for body surface area?. Nephrol Dial Transplant. 2008, 23: 4-6.CrossRefPubMed Geddes CC, Woo YM, Brady S: Glomerular filtration rate–what is the rationale and justification of normalizing GFR for body surface area?. Nephrol Dial Transplant. 2008, 23: 4-6.CrossRefPubMed
15.
go back to reference Rosner MH, Bolton WK: Renal function testing. Am J Kidney Dis. 2006, 47: 174-183. 10.1053/j.ajkd.2005.08.038.CrossRefPubMed Rosner MH, Bolton WK: Renal function testing. Am J Kidney Dis. 2006, 47: 174-183. 10.1053/j.ajkd.2005.08.038.CrossRefPubMed
16.
go back to reference Earley A, Miskulin D, Lamb EJ, Levey AS, Uhlig K: Estimating equations for glomerular filtration rate in the era of creatinine standardization: a systematic review. Ann Intern Med. 2012, 156: 785-270. 10.7326/0003-4819-156-11-201203200-00391.CrossRefPubMed Earley A, Miskulin D, Lamb EJ, Levey AS, Uhlig K: Estimating equations for glomerular filtration rate in the era of creatinine standardization: a systematic review. Ann Intern Med. 2012, 156: 785-270. 10.7326/0003-4819-156-11-201203200-00391.CrossRefPubMed
17.
go back to reference Redal-Baigorri B, Stokholm KH, Rasmussen K, Jeppesen N: Estimation of kidney function in cancer patients. Dan Med Bull. 2011, 58: A4236-PubMed Redal-Baigorri B, Stokholm KH, Rasmussen K, Jeppesen N: Estimation of kidney function in cancer patients. Dan Med Bull. 2011, 58: A4236-PubMed
18.
go back to reference Johnson DW, Jones GR, Becker GJ, Mathew TH: Automated reporting of eGFR: a useful tool for identifying and managing kidney disease. Med J Aust. 2009, 190: 200-203.PubMed Johnson DW, Jones GR, Becker GJ, Mathew TH: Automated reporting of eGFR: a useful tool for identifying and managing kidney disease. Med J Aust. 2009, 190: 200-203.PubMed
19.
go back to reference Delanaye P, Krzesinski JM: Indexing of renal function parameters by body surface area: intelligence or folly?. Nephron Clin Pract. 2011, 119: c289-c292.CrossRefPubMed Delanaye P, Krzesinski JM: Indexing of renal function parameters by body surface area: intelligence or folly?. Nephron Clin Pract. 2011, 119: c289-c292.CrossRefPubMed
20.
go back to reference Nyman HA, Dowling TC, Hudson JQ, Peter WL, Joy MS, Nolin TD: Comparative evaluation of the Cockcroft-Gault equation and the Modification of Diet in Renal Disease (MDRD) study equation for drug dosing: an opinion of the Nephrology Practice and Research Network of the American College of Clinical Pharmacy. Pharmacotherapy. 2011, 31: 1130-1144. 10.1592/phco.31.11.1130.CrossRefPubMed Nyman HA, Dowling TC, Hudson JQ, Peter WL, Joy MS, Nolin TD: Comparative evaluation of the Cockcroft-Gault equation and the Modification of Diet in Renal Disease (MDRD) study equation for drug dosing: an opinion of the Nephrology Practice and Research Network of the American College of Clinical Pharmacy. Pharmacotherapy. 2011, 31: 1130-1144. 10.1592/phco.31.11.1130.CrossRefPubMed
21.
go back to reference Matzke GR, Aronoff GR, Atkinson AJ, Bennett WM, Decker BS, Eckardt KU, et al: Drug dosing consideration in patients with acute and chronic kidney disease-a clinical update from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2011, 80: 1122-1137. 10.1038/ki.2011.322.CrossRefPubMed Matzke GR, Aronoff GR, Atkinson AJ, Bennett WM, Decker BS, Eckardt KU, et al: Drug dosing consideration in patients with acute and chronic kidney disease-a clinical update from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2011, 80: 1122-1137. 10.1038/ki.2011.322.CrossRefPubMed
Metadata
Title
The use of absolute values improves performance of estimation formulae: a retrospective cross sectional study
Authors
Belén Redal-Baigorri
Knud Rasmussen
James Goya Heaf
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2013
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/1471-2369-14-271

Other articles of this Issue 1/2013

BMC Nephrology 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.